ArticleJugan geon-gang gwa jilbyeong2024
[Long Term Follow Up of HIV Patients: Insight and Achievement from a 17 Years 'Korea HIV/AIDS Cohort Study' (2006-2023)].
Article in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recent HIV infections and associated risk factors among newly diagnosed individuals in South Korea (2016-2023).Scientific reports · 2025Article
- Testing the mediating effect of risk perception on the relationship between e-health literacy and infectious disease prevention behaviors among young adults based on the IMB model.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The "Korea HIV/AIDS Cohort Study" was initiated in 2006 to determine the factors affecting the progression of infection with the human immunodeficiency virus (HIV), onset of acquired immunodeficiency syndrome (AIDS), and resulting death and to ensure continuous efforts to improve the quality of life of the people infected with HIV. This cohort study was a large-scale multi-institution (16 medical institutions nationwide) cohort study in which approximately 10% of people living with HIV (PLWH) in the country participated, with the total number of study participants and the retention rate being 2,177 and 65.6%, respectively. The total numbers of case report forms (CRFs) and human resources (serum and plasma samples) collected were 22,349 and 15,765, respectively (as of October 10, 2023). Cohort statistics were continuously analyzed to understand the clinical and epidemiological characteristics of PLWH in the Republic of Korea (ROK). Over the past 17 years, research based on the Korean HIV/AIDS cohort study has led to the establishment of a robust operating system for cohort-based research, standardized research methods, and survey tools (such as CRFs) and the development of methods for standardizing and purifying data collected from multicenter cohorts. Systematic data management using this approach can provide a scientific basis for national HIV/AIDS prevention and disease management policies. ROK has established the 2nd Acquired Immune Deficiency Syndrome Prevention and Control Plan (2024-2028) with the vision of "zero new infections, zero deaths, and zero discrimination." The plan aims to reduce the number of new infections by 50% by 2030 compared with that in 2023, and various measures are being implemented to achieve this goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.